Pemazyre Wins Cost-Effectiveness Thumbs Up For Rare Bile Duct Cancer In England

NICE Said No To Bavencio For Urothelial Cancer

 
• By Neena Brizmohun
  
Pile of British money pounds sterling new one pound coins GBP in four piles close-up with NHS above. Rising cost of National Health Service concept UK
NICE says Pemazyre is a cost-effective use of NHS resources • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe